- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 894971, 6 pages
Triggering DTH and CTL Activity by fd Filamentous Bacteriophages: Role of CD4+ T Cells in Memory Responses
1Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, CNR, Via P. Castellino 111, 80131 Naples, Italy
2Institute of Protein Biochemistry, CNR, Via P. Castellino 111, 80131 Naples, Italy
Received 20 November 2009; Revised 4 February 2010; Accepted 13 February 2010
Academic Editor: Kim Klonowski
Copyright © 2010 Giovanna Del Pozzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Greenwood, A. E. Willis, and R. N. Perham, “Multiple display of foreign peptides on a filamentous bacteriophage: peptides from Plasmodium falciparum circumsporozoite protein as antigens,” Journal of Molecular Biology, vol. 220, no. 4, pp. 821–827, 1991.
- R. Jelinek, T. D. Terry, J. J. Gesell, P. Malik, R. N. Perham, and J. J. Opella, “NMR structure of the principal neutralizing determinant of HIV-1 displayed in filamentous bacteriophage coat protein,” Journal of Molecular Biology, vol. 266, no. 4, pp. 649–655, 1997.
- M. Gaubin, C. Fanutti, A. Durrbach, et al., “Processing by APC of filamentous phage displaying antigenic epitopes targets to both HLA class I and class II peptide loading compartments,” DNA Cell Biology, vol. 22, no. 1, pp. 11–18, 2003.
- P. De Berardinis, R. Sartorius, C. Fanutti, R. N. Perham, G. Del Pozzo, and J. Guardiola, “Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo,” Nature Biotechnology, vol. 18, no. 8, pp. 873–876, 2000.
- R. Sartorius, P. Pisu, L. D'Apice, et al., “The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2 restricted peptides and to induce strong anti-tumor CTL responses,” Journal of Immunology, vol. 108, no. 6, pp. 3719–3728, 2008.
- D. Mascolo, P. Barba, P. De Berardinis, F. Di Rosa, and G. Del Pozzo, “Phage display of a CTL epitope elicits a long-term in vivo cytotoxic response,” FEMS Immunology and Medical Microbiology, vol. 50, no. 1, pp. 59–66, 2007.
- P. Malik and R. N. Perham, “New vectors for peptide display on the surface of filamentous bacteriophage,” Gene, vol. 171, no. 1, pp. 49–51, 1996.
- J. C. Rice and R. P. Bucy, “Differences in the degree of depletion, rate of recovery and the preferential elimination of naïve T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice,” The Journal of Immunology, vol. 154, no. 12, pp. 6644–6654, 1995.
- P. Matzinger, “The JAM test. A simple assay for DNA fragmentation and cell death,” Journal of Immunological Methods, vol. 145, no. 1-2, pp. 185–192, 1991.
- A. Sulakvelidze, Z. Alavidze, and J. G. Morris, “Bacteriophage therapy,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 3, pp. 649–659, 2001.
- J. R. Clark and J. B. March, “Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials,” Trends in Biotechnology, vol. 24, no. 5, pp. 212–218, 2006.
- M. Trepel, W. Arap, and R. Pasqualini, “In vivo phage display and vascular heterogeneity: implications for targeted medicine,” Current Opinion in Chemical Biology, vol. 6, no. 3, pp. 399–404, 2002.
- J. Fang, G. Wang, Q. Yang, J. Song, Y. Wang, and L. Wang, “The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model,” Vaccine, vol. 23, no. 40, pp. 4860–4866, 2005.
- G. A. Waanders, D. Rimoldi, D. Lienard, et al., “Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line,” Clinical Cancer Research, vol. 3, no. 5, pp. 685–696, 1997.
- M. T. Clay, A. C. Obeika, P. J. Mosca, H. K. Lyerly, and M. A. Morse, “Assays for monitoring cellular immune responses to active immunotherapy of cancer,” Clinical Cancer Research, vol. 7, no. 5, pp. 1127–1135, 2001.
- F. M. Gordin, P. M. Hartigan, N. G. Klimas, S. B. Zolla-Pazner, M. S. Simberkoff, and J. D. Hamilton, “Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group,” Journal of Infectious Diseases, vol. 169, no. 4, pp. 893–897, 1994.
- E. M. Janssen, E. E. Lemmens, T. Wolfe, U. Christen, M. G. Von Herrath, and S. P. Schoenberger, “ T cells are required for secondary expansion and memory in T lymphocytes,” Nature, vol. 421, no. 6925, pp. 852–856, 2003.
- S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004.
- F. Granucci, I. Zanoni, S. Feau, and P. Ricciardi-Castagnoli, “Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity,” EMBO Journal, vol. 22, no. 11, pp. 2546–2551, 2003.